Profit taking after Private Equity sell out.
Crescent Capital bought what was hospital owner Healthscope's Australian pathology business for $105 million to create Australian Clinical Labs in 2015. AFR
The group is Australia's third-biggest pathology services provider with $443 million in revenue last financial year and an estimated 13.1 per cent market share, according to data collector IBISWorld. AFR
It also comes amid a rollercoaster ride for the country's pathology and radiology groups. Volumes were heavily affected in March and April as private hospitals and doctors cut back on non-emergency services. However, they have sprung back to life in recent months. AFR
Profit taking after Private Equity sell out. Crescent Capital...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.46 |
Change
-0.100(3.91%) |
Mkt cap ! $496.5M | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.54 | $2.45 | $2.838M | 1.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9385 | $2.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.49 | 5544 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| ACL (ASX) Chart |